ABOUT THE PRODUCT
ZELSUVMI™ (berdazimer) topical gel, 10.3%, is a U.S. FDA-approved treatment for molluscum contagiosum.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Pelthos Therapeutics
Xepi®
Pharmaceutical
N/A
Pelthos Therapeutics
United States (US)